3 out of 4 women are missing a nutrient that no doctor tests for

Why your GP does not know this value

Honestly: it is not because the omega-3 index does not matter. A standard blood count covers cell counts, haemoglobin and a differential. Even an extended panel with ferritin, vitamin D and thyroid values still has no omega-3 index. The reason is not medical, it is economic: the assay costs 40-60 euros, it is not a statutory-insurance benefit, and most labs do not offer it routinely.

The result? A systematic data gap. Clemens von Schacky, internist and co-inventor of the omega-3 index, put it well: many clinical omega-3 trials came back neutral because they never measured participants' baseline (von Schacky, 2021 [8]). Someone already at 7% barely benefits from extra fish oil. Someone at 3% can benefit substantially. Without a measurement you cannot judge need or effect. It is like writing a savings plan without looking at your account.

{{callout}}

What the research shows

I always tell the women I see: the omega-3 index has properly good data. The evidence has tightened in recent years, in four central areas.

Brain structure and cognition. The Framingham Heart Study (Satizabal et al., 2022 [2]) looked at 2,183 dementia-free adults (mean age 46, 53% women). A higher omega-3 index was associated with larger hippocampal volume and better abstract reasoning. And not only at 70 - already in midlife.

In young women (18-35), Cook et al. (2019) [3] found in a study of 288 participants: women with an O3I below 5.47% scored significantly worse on attention tests. The effect remained after adjustment for BMI, CRP and physical activity. So: your brain fog may not be a discipline problem.

Inflammation. McBurney et al. (2022) [5] analysed 28,871 healthy adults (51% women). An omega-3 index below 6.6% was associated with a higher neutrophil-to-lymphocyte ratio, an established marker of systemic inflammation. From 6.6% the immune picture stayed more balanced. Silent inflammation nobody feels, but which loads the body over time.

Depression. A meta-analysis of 26 RCTs (Liao et al., 2019 [6]) showed: EPA-dominant formulations (at least 60% EPA) at a maximum of 1 g per day had significant antidepressant effects. DHA-dominant preparations showed none. And this stays with me: depression affects women twice as often as men. If there is a measurable association, why are we not looking?

In pregnancy the association is even clearer. Hoge et al. (2019) [7] found: an O3I below 5% in early pregnancy was associated with a fivefold higher risk of postpartum depression. Fivefold. It is striking that this is still not measured as standard.

Pregnancy and preterm birth. The Cochrane review by Middleton et al. (2018) [4] pools 70 RCTs with 19,927 women: omega-3 supplementation reduced preterm births before 37 weeks by 11% and early preterm births before 34 weeks by 42%. Evidence quality: high.

What our aescolab data show

Our own analyses match the picture. Three out of four female clients sit below 8% on the omega-3 index, the lower bound of the functional optimum.

For comparison: the global Omega-3 World Map (Schuchardt et al., 2024 [1]) classifies Germany as “low” (4-6%). Only Scandinavia and Japan reach the target range. Undersupply in Germany is not an exception. It is the default. And most people do not know, because nobody measures it.

The aescolab reference ranges for the omega-3 index:

Why diet alone is usually not enough

I hear this a lot: “But I eat salmon!” In theory, two portions of oily sea fish a week supply enough EPA and DHA. In practice, few women in Germany hit that amount. And bioavailability varies with cooking method, fish origin and individual genetics.

The conversion rate from plant ALA (linseed oil, chia, walnuts) to EPA is 0.5-5%, to DHA under 0.5%. Plant omega-3 sources are therefore not an equivalent substitute for marine sources. Your linseed oil in muesli is great for other things, but it will not move your omega-3 index into the target range.

For omega-3 the same principle holds as for other biomarkers: without a baseline, every dose recommendation is speculative. Why that also applies to other supplements, I have explained here.

The only reliable method: measure, supplement in a targeted way, recheck after 8-12 weeks. How an extended blood panel differs from the GP standard is in the primer.

{{cta}}